Aura Biosciences, Inc. (AURA) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 75 transactions totaling $67.4M, demonstrating a bullish sentiment with $65.6M in net insider flow. The most recent transaction on Jan 20, 2026 involved a sale of 16,928 shares valued at $82.3K.
No significant insider buying has been recorded for AURA in the recent period.
No significant insider selling has been recorded for AURA in the recent period.
Based on recent SEC filings, insider sentiment for AURA is bullish with an Insider Alignment Score of 99/100 and a net flow of $65.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Aura Biosciences, Inc. (AURA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading AURA stock, having executed 75 transactions in the past 90 days. The most active insider is Capital Management Company, Lp Matrix (Executive), who has made 2 transactions totaling $29.0M.
Get notified when executives and directors at AURA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Pinos Elisabet De Los | Executive | Sale | 16,928 | $4.86 | $82.3K | |
| Jan 20, 2026 | Elazzouzi Amy | Senior Vice President, Finance | Sale | 1,581 | $4.86 | $7.7K | |
| Nov 17, 2025 | Jill Hopkins Janet | Executive | Sale | 17,109 | $5.42 | $92.7K | |
| Oct 29, 2025 | Pinos Elisabet De Los | Executive | Sale | 9,049 | $6.35 | $57.5K | |
| Oct 29, 2025 | Elazzouzi Amy | Executive | Sale | 896 | $6.35 | $5.7K | |
| Oct 16, 2025 | Plavsic Mark | Executive | Sale | 12,169 | $6.35 | $77.3K | |
| Aug 18, 2025 | Elazzouzi Amy | Executive | Option Exercise | 1,094 | $3.16 | $3.5K | |
| Aug 18, 2025 | Elazzouzi Amy | Executive | Option Exercise | 2,554 | $5.07 | $12.9K | |
| Aug 18, 2025 | Elazzouzi Amy | Executive | Sale | 7,722 | $6.70 | $51.7K | |
| Aug 18, 2025 | Elazzouzi Amy | Executive | Option Exercise | 4,744 | $2.74 | $13.0K | |
| Aug 18, 2025 | Elazzouzi Amy | Executive | Option Exercise | 547 | $5.48 | $3.0K | |
| Aug 18, 2025 | Elazzouzi Amy | Executive | Option Exercise | 547 | $5.21 | $2.8K | |
| Aug 18, 2025 | Elazzouzi Amy | Executive | Option Exercise | 1,094 | $5.48 | $6.0K | |
| Aug 18, 2025 | Elazzouzi Amy | Executive | Option Exercise | 2,319 | $4.25 | $9.9K | |
| Jun 20, 2024 | Michael Johnson David | Executive | Award | 10,500 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 27 | $66.5M | 98.6% |
Sale(S) | 17 | $902.6K | 1.3% |
Exercise(M) | 9 | $72.2K | 0.1% |
Award(A) | 17 | $0 | 0.0% |
Conversion(C) | 5 | $0 | 0.0% |
Insiders at Aura Biosciences, Inc. are accumulating shares at an accelerated pace. With 15 insiders making 75 transactions totaling $66.5M in purchases versus $902.6K in sales, the net buying activity of $65.6M signals strong executive confidence. Capital Management Company, Lp Matrix (Executive) leads the buying activity with $29.0M in transactions across all time.